Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $10.3 million versus the consensus estimate of $9.7 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.